| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.48 | 0.08 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |